Clinical trial

MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer

NCT06227546

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-04-15

PhasePHASE2

Study timeline

Study start (actual)2024-04-15Date precision: day

Registry last updated2026-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Extensive-stage Small-cell Lung Cancerunresolved

Interventions

MGC018DRUG

Sponsors & collaborators

Georgetown Universitylead sponsor

MacroGenicscollaborator

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06227546 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.